PDCD1 and neoplasm: In this study, it appears that our model may mimic this ‘exhausted” CTL state even during the early stages of tumor establishment and thus allow for evaluation of immunotherapies (i.e. PD-1 blockade in here) in the presence of exhausted anti-tumor CTLs.